glp1 tirzepatide side effects long term What are the long-term complications of taking tirzepatide (a glucagon-like peptide-1 (GLP-1) receptor agonist) in patients with a history of type 2 diabetes or obesity? GLP-1 and Muscle Loss: Semaglutide,

Short exposure to heat increases heart rate, expands blood vessels, and improves endothelial function

plantarum strains, which is what the clinical trial should clarify

Novo Nordisk A/S Key Target Audience Market Players Investors End-users Government Authorities Consulting and Research Firm Venture capitalists Value-Added Resellers (VARs) Recent Development In January 2023, Semaglutide (Wegovy- Novo Nordisk) has been licensed by the US Food and Drug Administration for the treatment of obesity in pediatric patients aged 12 and above

Contraindicated in patients with a personal or family history of MTC or MEN 2

Mounjaro: Targets both GLP-1 and GIP receptors, offering a dual-action mechanism that has shown greater effectiveness in controlling blood sugar and supporting weight loss